ProteoWise
PrivateLast Round
VC Round
Dec 13, 2024
Total Funding Raised
$6.55M
Company Overview
ProteoWise is a biotech company that has developed a high-throughput proteomics platform to enable faster and more cost-effective protein analysis for researchers.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProteoWise Comparables
Compare ProteoWise with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoMosaic | 83% | |
| Bio-Techne Corporation | 76% | |
| Bio-Rad Laboratories | 73% |
ProteoWise Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 13, 2024 | ||||
| VC Round | Apr 1, 2021 | ||||
| Grant | Sep 1, 2020 | ||||
| Series A | Mar 27, 2020 |
ProteoWise Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | VC Round, Series A |
| Co-Win Ventures | Series A |
| Taihill Venture | VC Round, Series A |
| Foothill Ventures | Series A, VC Round |
| National Institute on Aging | Grant |
| UniWill Ventures | VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors grew 2605% MoM, from 20 to 541.
- Dec 13, 2024
$10M round led by Connecticut Innovations.
ProteoWise Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ProteoWise's valuation, stock price, and market status.
Is ProteoWise a public or private company?
ProteoWise is a private company.
What is the current stock price of ProteoWise?
ProteoWise is a private company, so its shares have no public market price. Caplight tracks ProteoWise's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProteoWise worth (valuation)?
Valuation information for ProteoWise is not publicly available.
Can I buy ProteoWise stock?
ProteoWise shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProteoWise's last funding round?
ProteoWise's most recent funding round was VC Round on December 13, 2024.
Who are the main investors in ProteoWise?
Key investors in ProteoWise include Connecticut Innovations.
Will ProteoWise IPO soon?
No public IPO plans have been announced for ProteoWise.
How can I track ProteoWise secondary market activity?
Caplight tracks bids, offers, and trades in ProteoWise's shares on secondary markets.